Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Expression of human recombinant lipocortin I in a wheat-germ cell-free system and Xenopus oocytes. Lipocortin is not secreted.
Frey BM
,
Frey FJ
,
Lingappa VR
,
Trachsel H
.
???displayArticle.abstract???
Lipocortin I has been presumed to be synthesized and secreted in response to glucocorticoids yet the amino acid sequence of lipocortin I reveals no signal sequence typically necessary for proteins to enter the secretory pathway. The translocation of lipocortin I across membranes was analyzed in a cell-free system and in Xenopus oocytes. Based on the published sequence, the cDNA of human lipocortin I was cloned and expressed in Escherichia coli. Lipocortin I was purified and used to raise monoclonal antibodies. To test whether lipocortin I is secreted in vitro, transcribed lipocortin mRNA was translated in a wheat germ cell-free system in the absence and presence of microsomal membranes. Prolactin mRNA was used as a control for translocation of newly synthesized protein into membrane vesicles. Prolactin, but not lipocortin I, was translocated into the membranes. To test for secretion of lipocortin I in vivo, Xenopus oocytes were co-injected with transcripts encoding lipocortin I and prolactin, with and without the signal sequence. Prolactin with the signal sequence was released into the medium. However, neither prolactin without a signal sequence nor lipocortin I was released. Carbonate extraction, using an integral transmembrane protein as control, revealed no evidence for membrane integration of lipocortin I. Thus lipocortin I is not a secreted protein.
Bienkowski,
Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger.
1989, Pubmed
Bienkowski,
Inhibition of thromboxane A synthesis in U937 cells by glucocorticoids. Lack of evidence for lipocortin 1 as the second messenger.
1989,
Pubmed
Blackwell,
Suppression of arachidonate oxidation by glucocorticoid-induced antiphospholipase peptides.
1983,
Pubmed
Blackwell,
Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids.
1980,
Pubmed
Brönnegård,
Human calpactin II (lipocortin I) messenger ribonucleic acid is not induced by glucocorticoids.
1988,
Pubmed
Cirino,
Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung.
,
Pubmed
Cirino,
Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test.
1989,
Pubmed
Cirino,
Human recombinant lipocortin 1 inhibits prostacyclin production by human umbilical artery in vitro.
1987,
Pubmed
Davidson,
Inhibition of phospholipase A2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids.
1987,
Pubmed
Dawid,
Xenopus laevis in developmental and molecular biology.
1988,
Pubmed
,
Xenbase
Di Rosa,
Anti-phospholipase proteins.
1984,
Pubmed
Errasfa,
The presence of lipocortin in human embryonic skin fibroblasts and its regulation by anti-inflammatory steroids.
1985,
Pubmed
Flower,
Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation.
1979,
Pubmed
Fradin,
Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'.
1988,
Pubmed
Glenney,
Antibodies to the N-terminus of calpactin II (p35) affect Ca2+ binding and phosphorylation by the epidermal growth factor receptor in vitro.
1988,
Pubmed
Gupta,
Glucocorticoid-induced phospholipase A2-inhibitory proteins mediate glucocorticoid teratogenicity in vitro.
1984,
Pubmed
Gurdon,
Use of frog eggs and oocytes for the study of messenger RNA and its translation in living cells.
1971,
Pubmed
,
Xenbase
Gurpide,
Lipocortin output by human endometrium in vitro.
1986,
Pubmed
Hirata,
Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases.
1981,
Pubmed
Hirata,
The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation.
1981,
Pubmed
Hirata,
Role of lipomodulin, a phospholipase inhibitory protein, in immunoregulation by thymocytes.
1983,
Pubmed
Hullin,
Effect of dexamethasone on prostaglandin synthesis and on lipocortin status in human endothelial cells. Inhibition of prostaglandin I2 synthesis occurring without alteration of arachidonic acid liberation and of lipocortin synthesis.
1989,
Pubmed
Katz,
Transmembrane biogenesis of the vesicular stomatitis virus glycoprotein.
1979,
Pubmed
Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase
Köhler,
Continuous cultures of fused cells secreting antibody of predefined specificity.
1975,
Pubmed
Lingappa,
Intracellular traffic of newly synthesized proteins. Current understanding and future prospects.
1989,
Pubmed
Lundgren,
Dexamethasone inhibits respiratory glycoconjugate secretion from feline airways in vitro by the induction of lipocortin (lipomodulin) synthesis.
1988,
Pubmed
Maridonneau-Parini,
Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.
1989,
Pubmed
Parente,
Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins.
1984,
Pubmed
Pepinsky,
Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates.
1986,
Pubmed
Pfäffle,
Biosynthesis, secretion and extracellular localization of anchorin CII, a collagen-binding protein of the calpactin family.
1988,
Pubmed
Price,
Molecular cloning of matrix Gla protein: implications for substrate recognition by the vitamin K-dependent gamma-carboxylase.
1987,
Pubmed
Roman,
Inhibition of the transition of a 40 S ribosome-Met-tRNA-i-Met complex to an 80 S ribosome-Met-tRNA-i-Met- complex by 7-Methylguanosine-5'-phosphate.
1976,
Pubmed
Rosenberg,
Vectors for selective expression of cloned DNAs by T7 RNA polymerase.
1987,
Pubmed
Russo-Marie,
Dexamethasone-induced inhibition of prostaglandin production dose not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor.
1982,
Pubmed
Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed
Schwartz,
[Existence in Escherichia coli K 12 of a common regulation of the biosynthesis of bacteriophage receptors and maltose metabolism].
1967,
Pubmed
Silve,
The yeast acid phosphatase can enter the secretory pathway without its N-terminal signal sequence.
1987,
Pubmed
Simon,
Translocation of globin fusion proteins across the endoplasmic reticulum membrane in Xenopus laevis oocytes.
1987,
Pubmed
,
Xenbase
Solito,
Modulation of phospholipase A2 activity in human fibroblasts.
1989,
Pubmed
Studier,
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.
1986,
Pubmed
Verner,
Protein translocation across membranes.
1988,
Pubmed
Wallner,
Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity.
,
Pubmed
Walter,
Preparation of microsomal membranes for cotranslational protein translocation.
1983,
Pubmed
Zokas,
The calpactin light chain is tightly linked to the cytoskeletal form of calpactin I: studies using monoclonal antibodies to calpactin subunits.
1987,
Pubmed
van Binsbergen,
Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity.
1989,
Pubmed
